FDA clears two Meridian upper respiratory tests
This article was originally published in The Gray Sheet
Executive Summary
Meridian Bioscience receives FDA clearance Nov. 26 to market its Tru Flu and Tru RSV tests to detect influenza A and B viruses and respiratory syncytial virus, respectively. The tests are based on a new rapid test technology that features improved safety and space savings, the firm says